Cargando…

Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase

INTRODUCTION: Multipotent mesenchymal stromal cells (MSCs) have gained considerable interest because of their potential use in the treatment of a variety of diseases and injuries. Although remarkable advancements have been made in clinical studies, substantial concerns still regard the safety of MSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Melo, Carolina Soares Barros, Arantes Faria, Jerusa Araújo Quintão, Corrêa, Natássia Caroline Resende, de Andrade, Carolina, Carvalho, Juliana Lott, Goes, Alfredo M, Rodrigues, Michele A, Gomes, Dawidson Assis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854775/
https://www.ncbi.nlm.nih.gov/pubmed/23928293
http://dx.doi.org/10.1186/scrt291
_version_ 1782294858454532096
author Melo, Carolina Soares Barros
Arantes Faria, Jerusa Araújo Quintão
Corrêa, Natássia Caroline Resende
de Andrade, Carolina
Carvalho, Juliana Lott
Goes, Alfredo M
Rodrigues, Michele A
Gomes, Dawidson Assis
author_facet Melo, Carolina Soares Barros
Arantes Faria, Jerusa Araújo Quintão
Corrêa, Natássia Caroline Resende
de Andrade, Carolina
Carvalho, Juliana Lott
Goes, Alfredo M
Rodrigues, Michele A
Gomes, Dawidson Assis
author_sort Melo, Carolina Soares Barros
collection PubMed
description INTRODUCTION: Multipotent mesenchymal stromal cells (MSCs) have gained considerable interest because of their potential use in the treatment of a variety of diseases and injuries. Although remarkable advancements have been made in clinical studies, substantial concerns still regard the safety of MSCs. Some evidence suggests that MSCs can spontaneously generate a population of cells with tumorigenic potential. Thus, studying the molecular mechanisms that control the proliferation of MSCs may be a necessary step toward the development of strategies for safe clinical practice. Ca(2+) is a second messenger that mediates a wide range of cellular responses, including the regulation of cell proliferation, but little is known about its function in MSCs. The aim of this study was to investigate the effects of targeted Ca(2+) buffering on MSCs proliferation in vitro. METHODS: Here, we used an adenoviral (Ad) vector encoding the Ca(2+) chelator protein parvalbumin (PV) fused to a nuclear exclusion signal (NES) and the Discosoma red fluorescent protein (DsRed) to investigate the function of cytoplasmic Ca(2+) signals on MSC proliferation. Confocal microscopy was used to demonstrate that PV-NES-DsRed was expressed in the cytoplasm. Ca(2+) signaling was monitored by using Fluo-4-AM. Fluorescence-activated cell sorting (FACS) analysis of cells that were stained with propidium iodide was used as a quantitative measure of cell death. The mitotic index was assessed by immunofluorescence, and the expression of cyclins was examined with Western blot. RESULTS: Our results show that the Ad-PV-NES-DsRed fusion protein decreased serum-induced Ca(2+) signaling and blocked the proliferation of rat adipose-derived MSCs (AT-MSCs) in prophase. FACS analysis revealed that Ad-PV-NES-DsRed did not induce cell death in AT-MSCs. Furthermore, Western blot analysis demonstrated that Ad-PV-NES-DsRed reduced extracellular signal-regulated kinase (Erk1/2) phosphorylation and cyclin B1 expression. Buffering cytosolic Ca(2+) did not alter the expression of cyclins A/D1/D2/D3/E and E2. CONCLUSIONS: Our results show that cytoplasmic Ca(2+) signals are important for AT-MSCs progression beyond prophase because of their effects on Erk phosphorylation and cyclin B1 expression.
format Online
Article
Text
id pubmed-3854775
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38547752013-12-16 Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase Melo, Carolina Soares Barros Arantes Faria, Jerusa Araújo Quintão Corrêa, Natássia Caroline Resende de Andrade, Carolina Carvalho, Juliana Lott Goes, Alfredo M Rodrigues, Michele A Gomes, Dawidson Assis Stem Cell Res Ther Research INTRODUCTION: Multipotent mesenchymal stromal cells (MSCs) have gained considerable interest because of their potential use in the treatment of a variety of diseases and injuries. Although remarkable advancements have been made in clinical studies, substantial concerns still regard the safety of MSCs. Some evidence suggests that MSCs can spontaneously generate a population of cells with tumorigenic potential. Thus, studying the molecular mechanisms that control the proliferation of MSCs may be a necessary step toward the development of strategies for safe clinical practice. Ca(2+) is a second messenger that mediates a wide range of cellular responses, including the regulation of cell proliferation, but little is known about its function in MSCs. The aim of this study was to investigate the effects of targeted Ca(2+) buffering on MSCs proliferation in vitro. METHODS: Here, we used an adenoviral (Ad) vector encoding the Ca(2+) chelator protein parvalbumin (PV) fused to a nuclear exclusion signal (NES) and the Discosoma red fluorescent protein (DsRed) to investigate the function of cytoplasmic Ca(2+) signals on MSC proliferation. Confocal microscopy was used to demonstrate that PV-NES-DsRed was expressed in the cytoplasm. Ca(2+) signaling was monitored by using Fluo-4-AM. Fluorescence-activated cell sorting (FACS) analysis of cells that were stained with propidium iodide was used as a quantitative measure of cell death. The mitotic index was assessed by immunofluorescence, and the expression of cyclins was examined with Western blot. RESULTS: Our results show that the Ad-PV-NES-DsRed fusion protein decreased serum-induced Ca(2+) signaling and blocked the proliferation of rat adipose-derived MSCs (AT-MSCs) in prophase. FACS analysis revealed that Ad-PV-NES-DsRed did not induce cell death in AT-MSCs. Furthermore, Western blot analysis demonstrated that Ad-PV-NES-DsRed reduced extracellular signal-regulated kinase (Erk1/2) phosphorylation and cyclin B1 expression. Buffering cytosolic Ca(2+) did not alter the expression of cyclins A/D1/D2/D3/E and E2. CONCLUSIONS: Our results show that cytoplasmic Ca(2+) signals are important for AT-MSCs progression beyond prophase because of their effects on Erk phosphorylation and cyclin B1 expression. BioMed Central 2013-08-08 /pmc/articles/PMC3854775/ /pubmed/23928293 http://dx.doi.org/10.1186/scrt291 Text en Copyright © 2013 Melo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Melo, Carolina Soares Barros
Arantes Faria, Jerusa Araújo Quintão
Corrêa, Natássia Caroline Resende
de Andrade, Carolina
Carvalho, Juliana Lott
Goes, Alfredo M
Rodrigues, Michele A
Gomes, Dawidson Assis
Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase
title Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase
title_full Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase
title_fullStr Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase
title_full_unstemmed Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase
title_short Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase
title_sort cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854775/
https://www.ncbi.nlm.nih.gov/pubmed/23928293
http://dx.doi.org/10.1186/scrt291
work_keys_str_mv AT melocarolinasoaresbarros cytoplasmictargetedparvalbuminblockstheproliferationofmultipotentmesenchymalstromalcellsinprophase
AT arantesfariajerusaaraujoquintao cytoplasmictargetedparvalbuminblockstheproliferationofmultipotentmesenchymalstromalcellsinprophase
AT correanatassiacarolineresende cytoplasmictargetedparvalbuminblockstheproliferationofmultipotentmesenchymalstromalcellsinprophase
AT deandradecarolina cytoplasmictargetedparvalbuminblockstheproliferationofmultipotentmesenchymalstromalcellsinprophase
AT carvalhojulianalott cytoplasmictargetedparvalbuminblockstheproliferationofmultipotentmesenchymalstromalcellsinprophase
AT goesalfredom cytoplasmictargetedparvalbuminblockstheproliferationofmultipotentmesenchymalstromalcellsinprophase
AT rodriguesmichelea cytoplasmictargetedparvalbuminblockstheproliferationofmultipotentmesenchymalstromalcellsinprophase
AT gomesdawidsonassis cytoplasmictargetedparvalbuminblockstheproliferationofmultipotentmesenchymalstromalcellsinprophase